HTB homepage • Conference reports • Articles by subject • Subscribe May 2006 Contents Editorial Volume 7 Number 5 May 2006 Conference reports 12th Annual Conference of the British HIV Association, 29 March-1 April 2006, Brighton HIV in the UK summaries from BHIVA 12th annual conference Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions Dosing rifabutin and lopinavir/r sub-optimal rifabutin levels reported in five patients dosed according to current guidelines Fatal seronegative visceral leishmaniasis in Portuguese patient Awareness of PEP after sexual exposure (PEPSE) Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy Causes of death in adults receiving ARV therapy in Senegal Rapid scale-up of treatment in Zambia delivered at primary health level The effect of HIV subtype on disease progression in Rakai, Uganda Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load Once-daily FTC, ddI, and efavirenz in children and adolescents Simplified triple NRTI regimen effective in vertically infected children: two years follow-up Long-term clinical and biological outcomes in children vertically infected with HIV Prospective follow up of children with lipodystrophy Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB Nevirapine pharmacokinetics with infant prophylaxis Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques A genome armed against HIV Circumcision: a surprising benefit from an unkind cut Topical microbicides: the real front line of HIV prevention Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy Antiretrovirals Development of d-d4FC (dexelvucitabine, Reverset) discontinued Treatment access Lopinavir/r (meltrex) filed in South Africa Indian community organisations file first opposition against patent application ITPC Indian Mailbox database now online Global fund review: timing of Round 6 still unclear Other news Letter from Sir Liam Donaldson to all Chief Executives of Primary Care Trusts and Strategic Health Authorities in England Knowledge about HIV transmission in the UK declined over last five years Volunteer opportunity: improve healthcare for HIV-positive children in developing countries On the web Microbicides 2006 Conference, 23-26 April 2006, Cape Town, South Africa HIV inSite Knowledge Base: new and updated chapters and lectures Johns Hopkins pocket guide to HIV & AIDS treatment PDFs Volume 7 Number 5 May 2006 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
